University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a "two-in-one" molecule that ...

University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a "two-in-one" molecule that can simultaneously turn off two notoriously difficult-to-target ...

Northwestern Medicine investigators have discovered a new combination approach that may improve the efficacy of MYC inhibitor drugs for treating aggressive and treatment-resistant cancers, according ...

Scientists created a molecular switch that can revert the fate of cancer cells back to a normal state by capturing the moment ...

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making ...

This review calls attention to MYC as not just a notorious oncogene, but a gateway to novel, more effective cancer treatments —redefining what is therapeutically possible for one of the most ...

Obesity elevates the risk of at least 13 major cancers, including those of the breast, colon and liver. It also impairs immune responses that target tumors and are stimulated by cancer immunotherapies ...

A new physiological salt-based method enables high-resolution transcription factor mapping in small and single-cell samples.